Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1900

1.

High Prevalence of Cerebral Small Vessel Disease on 7T Magnetic Resonance Imaging in Familial Hypercholesterolemia.

Todate Y, Uwano I, Yashiro S, Chida A, Hasegawa Y, Oda T, Nagasawa K, Honma H, Sasaki M, Ishigaki Y.

J Atheroscler Thromb. 2019 Mar 15. doi: 10.5551/jat.48553. [Epub ahead of print]

2.

Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction.

Liu J, Nishida M, Inui H, Chang J, Zhu Y, Kanno K, Matsuda H, Sairyo M, Okada T, Nakaoka H, Ohama T, Masuda D, Koseki M, Yamashita S, Sakata Y.

J Atheroscler Thromb. 2019 Mar 14. doi: 10.5551/jat.48405. [Epub ahead of print]

3.

Serum Anti-Apo B Antibody Level as Residual CVD Marker in DM Patients under Statin Treatment.

Yamamoto H, Kawamura M, Kochi I, Imai M, Murata Y, Suzuki T, Chen Y, Hashimoto K, Kihara S.

J Atheroscler Thromb. 2019 Mar 14. doi: 10.5551/jat.46797. [Epub ahead of print]

4.

Acquired von Willebrand Syndrome Associated with Cardiovascular Diseases.

Horiuchi H, Doman T, Kokame K, Saiki Y, Matsumoto M.

J Atheroscler Thromb. 2019 Mar 12. doi: 10.5551/jat.RV17031. [Epub ahead of print]

5.
6.

Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.

Sánchez E, Betriu À, Yeramian A, Fernández E, Purroy F, Sánchez-de-la-Torre M, Pamplona R, Miquel E, Kerkeni M, Hernández C, Simó R, Lecube A; ILERVAS project; ILERVAS Project:, Hernández M, Rius F, Polanco D, Barbé F, Torres G, Suárez G, Portero-Otin M, Jové M, Colàs-Campàs L, Benabdelhak I, Farràs C, Ortega M, Manuel Valdivielso J, Bermúdez-López M, Martínez-Alonso M.

J Atheroscler Thromb. 2019 Mar 6. doi: 10.5551/jat.47498. [Epub ahead of print]

7.

One-Year Clinical Outcomes following Implantation of InnovaTM Self-Expanding Nitinol Stents in Patients with Peripheral Artery Diseases Presenting Femoropopliteal Artery Lesions.

Tsujimura T, Takahara M, Iida O, Hiramori S, Hayakawa N, Karashima E, Miura T, Teramura M, Ichihashi K, Kojima T, Aihara H, Yamaoka T, Fujihara M, Tosaka A, Doijiri T, Mano T, Soga Y.

J Atheroscler Thromb. 2019 Mar 5. doi: 10.5551/jat.47399. [Epub ahead of print]

8.

Prognostic Value of Plasma Big Endothelin-1 Level among Patients with Three-Vessel Disease: A Cohort Study.

Zhang C, Tian J, Jiang L, Xu L, Liu J, Zhao X, Feng X, Wang D, Zhang Y, Sun K, Xu B, Zhao W, Hui R, Gao R, Yuan J, Song L.

J Atheroscler Thromb. 2019 Mar 1. doi: 10.5551/jat.47324. [Epub ahead of print]

9.
10.

Which is the Best Predictor for the Development of Atherosclerosis Among Circulating Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase?

Kobayashi J.

J Atheroscler Thromb. 2019 Feb 27. doi: 10.5551/jat.ED108. [Epub ahead of print] No abstract available.

11.

Sleep Disordered Breathing and Cardiovascular Diseases.

Yoshihisa A, Takeishi Y.

J Atheroscler Thromb. 2019 Feb 28. doi: 10.5551/jat.RV17032. [Epub ahead of print]

12.

Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus.

Randrianarisoa E, Lehn-Stefan A, Hieronimus A, Rietig R, Fritsche A, Machann J, Balletshofer B, Häring HU, Stefan N, Rittig K.

J Atheroscler Thromb. 2019 Feb 19. doi: 10.5551/jat.47274. [Epub ahead of print]

13.

High Serum Secreted Frizzled-Related Protein 5 Levels Associated with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.

Du Y, Zhao Y, Zhu Y, Hu C, Zhang J, Ji Q, Liu W, Han H, Yang L, Zhang D, Tong S, Wang Z, Guo Y, Liu X, Zhou Y.

J Atheroscler Thromb. 2019 Feb 15. doi: 10.5551/jat.47019. [Epub ahead of print]

14.

Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.

Furuhashi M.

J Atheroscler Thromb. 2019 Mar 1;26(3):216-232. doi: 10.5551/jat.48710. Epub 2019 Feb 7.

15.

Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan.

Hsu H, Hsu P, Cheng MH, Ito Y, Kanda E, Schaefer EJ, Ai M.

J Atheroscler Thromb. 2019 Feb 7. doi: 10.5551/jat.48330. [Epub ahead of print]

16.

Association between Prescription and Control Status of Dyslipidemia and Hypertension among Japanese Patients with Diabetes.

Sakamoto M, Edo N, Takahashi S, Okamura E, Uno K, Morita K, Ishikawa T, Asahi K, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kimura K, Ohashi Y, Watanabe T, Tsukamoto K.

J Atheroscler Thromb. 2019 Feb 6. doi: 10.5551/jat.47597. [Epub ahead of print]

17.

Patients with Acute Ischemic Cerebrovascular Disease with Coronary Artery Stenosis Have More Diffused Cervicocephalic Atherosclerosis.

Kong Q, Ma X, Wang C, Feng W, Ovbiagele B, Zhang Y, Du X.

J Atheroscler Thromb. 2019 Feb 6. doi: 10.5551/jat.47464. [Epub ahead of print]

18.

Self-Reported Eczema in Relation with Mortality from Cardiovascular Disease in Japanese: the Japan Collaborative Cohort Study.

Nishida Y, Kubota Y, Iso H, Tamakoshi A; JACC Study Group.

J Atheroscler Thromb. 2019 Jan 31. doi: 10.5551/jat.46383. [Epub ahead of print]

19.

Association of Plasma Pentraxin-3 Level with Lipid Levels and Cardiovascular Risk Factors in People with No History of Lipid-Lowering Medication: the Dong-gu Study.

Lee R, Ahn HR, Shin MH, Kim HN, Lee YH, Choi SW, Kweon SS.

J Atheroscler Thromb. 2019 Jan 23. doi: 10.5551/jat.47167. [Epub ahead of print]

20.

Diagnosis and Management of Statin Intolerance.

Alonso R, Cuevas A, Cafferata A.

J Atheroscler Thromb. 2019 Mar 1;26(3):207-215. doi: 10.5551/jat.RV17030. Epub 2019 Jan 19.

Supplemental Content

Loading ...
Support Center